Jonathan Block
Stock Analyst at Stifel
(4.26)
# 355
Out of 5,182 analysts
232
Total ratings
52.2%
Success rate
14.47%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRUP Trupanion | Maintains: Hold | $35 → $31 | $25.47 | +21.71% | 18 | Mar 31, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $775 → $675 | $574.80 | +17.43% | 24 | Mar 31, 2026 | |
| NYXH Nyxoah | Maintains: Buy | $11 → $10 | $3.29 | +203.95% | 12 | Mar 20, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $95 → $85 | $54.42 | +56.19% | 15 | Mar 5, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $20 → $22 | $18.28 | +20.35% | 3 | Feb 20, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $25 → $22 | $9.73 | +126.10% | 4 | Feb 18, 2026 | |
| ALGN Align Technology | Maintains: Buy | $200 → $210 | $166.87 | +25.85% | 41 | Feb 5, 2026 | |
| PODD Insulet | Maintains: Buy | $370 → $350 | $202.46 | +72.87% | 2 | Feb 4, 2026 | |
| RMD ResMed | Maintains: Hold | $260 → $265 | $226.05 | +17.23% | 5 | Jan 30, 2026 | |
| COO The Cooper Companies | Reiterates: Buy | $85 → $95 | $69.66 | +36.38% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $130 | $116.80 | +11.30% | 24 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $9 | $6.76 | +33.14% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $85 | $63.11 | +34.69% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $23 | $22.80 | +0.88% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $17 | $11.52 | +47.57% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $80 → $75 | $73.85 | +1.56% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.27 | -35.54% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $2 | $0.88 | +128.05% | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.35 | +407.46% | 1 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.03 | +288.35% | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $45 | $76.01 | -40.80% | 8 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $32 → $35 | $115.06 | -69.58% | 5 | Aug 3, 2018 |
Trupanion
Mar 31, 2026
Maintains: Hold
Price Target: $35 → $31
Current: $25.47
Upside: +21.71%
IDEXX Laboratories
Mar 31, 2026
Maintains: Buy
Price Target: $775 → $675
Current: $574.80
Upside: +17.43%
Nyxoah
Mar 20, 2026
Maintains: Buy
Price Target: $11 → $10
Current: $3.29
Upside: +203.95%
Inspire Medical Systems
Mar 5, 2026
Maintains: Buy
Price Target: $95 → $85
Current: $54.42
Upside: +56.19%
Tandem Diabetes Care
Feb 20, 2026
Maintains: Hold
Price Target: $20 → $22
Current: $18.28
Upside: +20.35%
Beta Bionics
Feb 18, 2026
Maintains: Buy
Price Target: $25 → $22
Current: $9.73
Upside: +126.10%
Align Technology
Feb 5, 2026
Maintains: Buy
Price Target: $200 → $210
Current: $166.87
Upside: +25.85%
Insulet
Feb 4, 2026
Maintains: Buy
Price Target: $370 → $350
Current: $202.46
Upside: +72.87%
ResMed
Jan 30, 2026
Maintains: Hold
Price Target: $260 → $265
Current: $226.05
Upside: +17.23%
The Cooper Companies
Dec 5, 2025
Reiterates: Buy
Price Target: $85 → $95
Current: $69.66
Upside: +36.38%
Nov 18, 2025
Maintains: Hold
Price Target: $140 → $130
Current: $116.80
Upside: +11.30%
Oct 21, 2025
Reinstates: Hold
Price Target: $9
Current: $6.76
Upside: +33.14%
Oct 21, 2025
Reinstates: Buy
Price Target: $85
Current: $63.11
Upside: +34.69%
Sep 24, 2025
Maintains: Buy
Price Target: $18 → $23
Current: $22.80
Upside: +0.88%
Aug 8, 2025
Maintains: Hold
Price Target: $19 → $17
Current: $11.52
Upside: +47.57%
Jul 25, 2025
Downgrades: Hold
Price Target: $80 → $75
Current: $73.85
Upside: +1.56%
Feb 27, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $23.27
Upside: -35.54%
Jul 26, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.88
Upside: +128.05%
Nov 27, 2023
Reiterates: Buy
Price Target: $17
Current: $3.35
Upside: +407.46%
May 12, 2020
Maintains: Buy
Price Target: $5 → $4
Current: $1.03
Upside: +288.35%
Apr 8, 2020
Maintains: Hold
Price Target: $52 → $45
Current: $76.01
Upside: -40.80%
Aug 3, 2018
Maintains: Hold
Price Target: $32 → $35
Current: $115.06
Upside: -69.58%